The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories.


Journal

The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460

Informations de publication

Date de publication:
11 2021
Historique:
received: 30 12 2020
accepted: 06 04 2021
pubmed: 18 4 2021
medline: 15 12 2021
entrez: 17 4 2021
Statut: epublish

Résumé

Patients with concomitant features of asthma and chronic obstructive pulmonary disease (COPD) have a heavy disease burden.Using data collected prospectively in the European Community Respiratory Health Survey, we compared the risk factors, clinical history and lung function trajectories from early adulthood to late sixties of middle-aged subjects with asthma+COPD (n=179), past (n=263) or current (n=808) asthma alone, COPD alone (n=111) or none of these (n=3477).Interview data and pre-bronchodilator forced expiratory volume in 1 s (FEV

Identifiants

pubmed: 33863744
pii: 13993003.04656-2020
doi: 10.1183/13993003.04656-2020
pmc: PMC8613837
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : G0901214
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright ©The authors 2021.

Déclaration de conflit d'intérêts

Conflict of interest: A. Marcon has nothing to disclose. Conflict of interest: F. Locatelli has nothing to disclose. Conflict of interest: S.C. Dharmage has nothing to disclose. Conflict of interest: C. Svanes has nothing to disclose. Conflict of interest: J. Heinrich has nothing to disclose. Conflict of interest: B. Leynaert has nothing to disclose. Conflict of interest: P. Burney has nothing to disclose. Conflict of interest: A. Corsico has nothing to disclose. Conflict of interest: G. Caliskan has nothing to disclose. Conflict of interest: L. Calciano has nothing to disclose. Conflict of interest: T. Gislason has nothing to disclose. Conflict of interest: C. Janson has nothing to disclose. Conflict of interest: D. Jarvis has nothing to disclose. Conflict of interest: R. Jõgi received grants from the Estonian Research Council (Personal Research Grant n. 562), and personal fees for consultancy and lecturing from GSK, Boehringer and Novartis, and for travels/accommodation/meetings from GSK and Boehringer. Conflict of interest: T. Lytras has nothing to disclose. Conflict of interest: A. Malinovschi has nothing to disclose. Conflict of interest: N. Probst-Hensch has nothing to disclose. Conflict of interest: K. Toren has nothing to disclose. Conflict of interest: L. Casas has nothing to disclose. Conflict of interest: G. Verlato has nothing to disclose. Conflict of interest: J. Garcia-Aymerich has nothing to disclose. Conflict of interest: S. Accordini has nothing to disclose.

Références

Lancet Respir Med. 2015 Sep;3(9):719-728
pubmed: 26255108
J Allergy Clin Immunol. 2007 Mar;119(3):611-7
pubmed: 17258304
J Allergy Clin Immunol Pract. 2020 Feb;8(2):483-495
pubmed: 31740296
Lancet Respir Med. 2018 Jul;6(7):535-544
pubmed: 29628376
N Engl J Med. 2015 Sep 24;373(13):1241-9
pubmed: 26398072
Eur Respir J. 2015 Sep;46(3):671-9
pubmed: 26113674
Am J Respir Crit Care Med. 1995 Nov;152(5 Pt 2):S77-121
pubmed: 7582322
Indoor Air. 2019 Jul;29(4):670-679
pubmed: 30963644
Eur Respir J. 2017 May 1;49(5):
pubmed: 28461307
J Allergy Clin Immunol. 2019 Apr;143(4):1598-1606
pubmed: 30291842
Respir Res. 2019 Oct 23;20(1):229
pubmed: 31647021
J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2326-2336.e5
pubmed: 31034998
Thorax. 2014 Sep;69(9):805-10
pubmed: 24646659
Lancet Respir Med. 2019 Apr;7(4):358-364
pubmed: 30765254
Environ Res. 2021 Mar;194:110703
pubmed: 33417909
Lancet Respir Med. 2018 Jan;6(1):29-39
pubmed: 29108938
Eur Respir J. 2014 Jan;43(1):250-63
pubmed: 23471349
Chronic Obstr Pulm Dis. 2017 Feb 3;4(2):87-96
pubmed: 28848917
BMJ. 2017 Sep 25;358:j3772
pubmed: 28947632
Eur Respir J. 2012 Apr;39(4):883-92
pubmed: 22005911
Eur Respir J. 1997 Nov;10(11):2495-501
pubmed: 9426085
J Allergy Clin Immunol. 2016 Jun;137(6):1788-1795.e9
pubmed: 26586040
Chest. 2003 Aug;124(2):474-81
pubmed: 12907531
Respirology. 2020 Aug;25(8):836-849
pubmed: 32064708
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Clin Exp Allergy. 2019 Jul;49(7):969-979
pubmed: 30934155
Arch Bronconeumol. 2012 Sep;48(9):331-7
pubmed: 22341911
Respiration. 2014;87(1):63-74
pubmed: 24029561
PLoS One. 2018 Aug 22;13(8):e0201881
pubmed: 30133533
Int J Chron Obstruct Pulmon Dis. 2016 Sep 07;11:2149-2155
pubmed: 27660432
Eur Respir J. 1994 May;7(5):954-60
pubmed: 8050554
Lancet Respir Med. 2016 Jun;4(6):454-62
pubmed: 27061878
Respir Res. 2018 Mar 2;19(1):36
pubmed: 29499758
Int J Epidemiol. 2018 Aug 1;47(4):1106-1117
pubmed: 29534228
J Allergy Clin Immunol. 2016 Dec;138(6):1571-1579.e10
pubmed: 27345171
N Engl J Med. 2015 Jul 9;373(2):111-22
pubmed: 26154786
Thorax. 2010 Jan;65(1):14-20
pubmed: 19729360
J Allergy Clin Immunol Pract. 2020 Mar;8(3):980-988.e10
pubmed: 31704441
Thorax. 2018 Sep;73(9):825-832
pubmed: 29720562
Eur Respir J. 2012 Dec;40(6):1324-43
pubmed: 22743675
Occup Environ Med. 2019 Apr;76(4):222-229
pubmed: 30700596
Thorax. 2015 Jul;70(7):683-91
pubmed: 25948695
Am J Respir Crit Care Med. 2016 Dec 1;194(11):1358-1365
pubmed: 27224255
Am J Respir Crit Care Med. 2017 Aug 1;196(3):375-381
pubmed: 28636425
Eur Respir J. 2002 Nov;20(5):1071-9
pubmed: 12449157
Am J Respir Crit Care Med. 2017 Jul 1;196(1):39-46
pubmed: 28146643
PLoS One. 2013 May 10;8(5):e62985
pubmed: 23675448
Chest. 2018 Feb;153(2):368-377
pubmed: 29248621

Auteurs

Alessandro Marcon (A)

Unit of Epidemiology and Medical Statistics, Dept of Diagnostics and Public Health, University of Verona, Verona, Italy alessandro.marcon@univr.it.

Francesca Locatelli (F)

Unit of Epidemiology and Medical Statistics, Dept of Diagnostics and Public Health, University of Verona, Verona, Italy.

Shyamali C Dharmage (SC)

Allergy and Lung Health Unit, School of Population and Global Health, The University of Melbourne, Melbourne, Australia.

Cecilie Svanes (C)

Centre for International Health, Dept of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Dept of Occupational Medicine, Haukeland University Hospital, Bergen, Norway.

Joachim Heinrich (J)

Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital of Ludwig Maximilians University, Comprehensive Pneumology Centre Munich, German Centre for Lung Research, Munich, Germany.

Bénédicte Leynaert (B)

Université Paris-Saclay, UVSQ, Université Paris-Sud, Inserm, Équipe d'Épidémiologie Respiratoire Intégrative, CESP, Villejuif, France.

Peter Burney (P)

National Heart and Lung Institute, Imperial College London, London, UK.
MRC-PHE Centre for Environment and Health, Imperial College London, London, UK.

Angelo Corsico (A)

Division of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation - Dept of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.

Gulser Caliskan (G)

Unit of Epidemiology and Medical Statistics, Dept of Diagnostics and Public Health, University of Verona, Verona, Italy.

Lucia Calciano (L)

Unit of Epidemiology and Medical Statistics, Dept of Diagnostics and Public Health, University of Verona, Verona, Italy.

Thorarinn Gislason (T)

Dept of Sleep, Landspitali University Hospital, Reykjavik, Iceland.
Medical Faculty, University of Iceland, Reykjavik, Iceland.

Christer Janson (C)

Dept of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.

Deborah Jarvis (D)

National Heart and Lung Institute, Imperial College London, London, UK.
MRC-PHE Centre for Environment and Health, Imperial College London, London, UK.

Rain Jõgi (R)

Lung Clinic, Tartu University Hospital, Tartu, Estonia.

Theodore Lytras (T)

Institute for Global Health (ISGlobal), Barcelona, Spain.
School of Medicine, European University Cyprus, Nicosia, Cyprus.

Andrei Malinovschi (A)

Dept of Medical Sciences: Clinical Physiology, Uppsala University, Uppsala, Sweden.

Nicole Probst-Hensch (N)

Dept of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.

Kjell Toren (K)

Occupational and Environmental Medicine, School of Public Health, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Lidia Casas (L)

Epidemiology and Social Medicine, University of Antwerp, Antwerp, Belgium.

Giuseppe Verlato (G)

Unit of Epidemiology and Medical Statistics, Dept of Diagnostics and Public Health, University of Verona, Verona, Italy.

Judith Garcia-Aymerich (J)

Institute for Global Health (ISGlobal), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.

Simone Accordini (S)

Unit of Epidemiology and Medical Statistics, Dept of Diagnostics and Public Health, University of Verona, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH